BeStock  
Markets › Compare › TBPH vs MLTX

TBPH vs MLTX

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
TBPH · Theravance Biopharma(Delisted)$0.00 ▲ 0.00%
MLTX · MoonLake Immunotherapeutics$11.07 ▲ 0.36%

Head to head

MetricTBPHMLTX
Price$0.00$11.07
Change today▲ 0.00%▲ 0.36%
Market cap$884.18M$942.13M
Return, 3 months–-28.0%
Return, year to date–-16.0%
Return, 1 year–-12.6%
P/E (TTM)16.4–
P/B3.12.5
P/E percentile vs own 5y85th87th
Dividend yield––
Revenue growth (YoY, latest qtr)-20.9%–
Net profit growth (YoY)-110.8%-12.5%
Gross margin––
Operating margin9.2%–
Net margin51.6%–
Return on equity20.9%-81.6%
Analyst target vs. price–+221.3%
Analyst buy share–88%
RSI (14)–44
30-day volatility–80.9%
Max drawdown, 1 year–-56.9%
Trend read–Strong downtrend
Analyst consensus–Buy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • MLTX is the largest of the group by market value.

Go deeper

Scroll to Top